Sequential antimicrobial therapy in mediastinitis after cardiac surgery: An observational study of 81 cases

Joffrey Eduardo Luján-Valencia1, Luis Eduardo López-Cortes2, Román Calvo-Jambrina1

  • 1Cardiology Unit, Hospital Universitario Virgen Macarena, Seville, Spain.

Abstract

Insights

Sequential therapy for post-surgical mediastinitis is effective. This approach, transitioning from intravenous to oral antibiotics, reduced hospital stays and mortality compared to exclusively intravenous treatments, with similar cure rates.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Pharmacology

Background:

  • Mediastinitis is a rare but severe complication following cardiac surgery.
  • Established antimicrobial treatment guidelines for mediastinitis are lacking.
  • This study evaluates sequential intravenous to oral therapy for post-surgical mediastinitis.

Purpose of the Study:

  • To assess the efficacy of sequential intravenous to oral antimicrobial therapy in selected patients with post-surgical mediastinitis.
  • To compare cure rates, relapse rates, and hospital stay duration between sequential and exclusively intravenous treatment groups.

Main Methods:

  • Retrospective observational study of 81 patients with post-surgical mediastinitis (2002-2016).
  • Patients were categorized based on receiving sequential intravenous to oral therapy or exclusively intravenous therapy.
  • Outcomes analyzed included cure, relapse, hospital stay, and mortality.

Main Results:

  • Sequential therapy was administered to 48 patients, starting median day 15.
  • The sequential therapy group experienced significantly shorter hospital stays (57.57 vs. 84.35 days) and lower in-hospital mortality (2.1% vs. 15.2%).
  • Cure rates were high in both groups (92.8% overall), with no significant difference in relapse rates.

Conclusions:

  • Sequential intravenous to oral antimicrobial therapy is a viable and effective option for selected post-surgical mediastinitis patients.
  • This approach can reduce hospital length of stay and mortality risks.
  • Sequential therapy offers comparable efficacy to exclusively intravenous treatment with potential benefits in resource utilization.

Related Concept Videos